Author: Lane, Thomas R.; Ekins, Sean
Title: Towards the Target: Tilorone, Quinacrine and Pyronaridine Bind to Ebola Virus Glycoprotein Cord-id: 2si7l1lz Document date: 2020_5_28
ID: 2si7l1lz
Snippet: Pyronaridine, tilorone and quinacrine were recently identified by a machine learning model and demonstrated in vitro and in vivo activity against Ebola virus (EBOV) and represent viable candidates for drug repurposing. These drugs were docked into the crystal structure of the ebola glycoprotein and then experimentally validated in vitro to generate Kd values for tilorone (0.73 μM) pyronaridine (7.34 μM), and quinacrine (7.55 μM). These are more potent than the previously reported toremifene (
Document: Pyronaridine, tilorone and quinacrine were recently identified by a machine learning model and demonstrated in vitro and in vivo activity against Ebola virus (EBOV) and represent viable candidates for drug repurposing. These drugs were docked into the crystal structure of the ebola glycoprotein and then experimentally validated in vitro to generate Kd values for tilorone (0.73 μM) pyronaridine (7.34 μM), and quinacrine (7.55 μM). These are more potent than the previously reported toremifene (16 μM).
Search related documents:
Co phrase search for related documents- additive effect and lysosomotropic effect: 1, 2
- additive effect and machine learning: 1, 2
- lysosomotropic effect and machine learning: 1, 2
Co phrase search for related documents, hyperlinks ordered by date